Baseline characteristics

Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-052) · Source last updated 2023-03-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      374

   units

   Participants

groups

1. description

   Participants received pembrolizumab 200 mg by IV infusion on Day 1 of each 21-day cycle (Q3W) for up to 2 years. Eligible participants who stopped the initial course of pembrolizumab due to complete response (CR) or completed initial course of pembrolizumab and had stable disease but progressed after discontinuation, initiated a second course of pembrolizumab at the investigator's discretion for up to an additional year.

   id

   BG000

   title

   Pembrolizumab 200 mg

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            9.9

            value

            73.0

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   title

   Age, Continuous

   unit Of Measure

   Years

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            86

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            288

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Sex: Female, Male

   unit Of Measure

   Participants

3. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            22

         title

         Hispanic or Latino

      2. measurements

         1. group Id

            BG000

            value

            326

         title

         Not Hispanic or Latino

      3. measurements

         1. group Id

            BG000

            value

            26

         title

         Unknown or Not Reported

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Ethnicity (NIH/OMB)

   unit Of Measure

   Participants

4. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            2

         title

         American Indian or Alaska Native

      2. measurements

         1. group Id

            BG000

            value

            26

         title

         Asian

      3. measurements

         1. group Id

            BG000

            value

            0

         title

         Native Hawaiian or Other Pacific Islander

      4. measurements

         1. group Id

            BG000

            value

            8

         title

         Black or African American

      5. measurements

         1. group Id

            BG000

            value

            332

         title

         White

      6. measurements

         1. group Id

            BG000

            value

            2

         title

         More than one race

      7. measurements

         1. group Id

            BG000

            value

            4

         title

         Unknown or Not Reported

   param Type

   COUNT_OF_PARTICIPANTS

   title

   Race (NIH/OMB)

   unit Of Measure

   Participants

population Description

The baseline analysis population consisted of all allocated participants.

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice